Warburg Pincus-Led Investor Group Agrees to Acquire Controlling Interest in PANTHERx® Rare

Investment will support continued innovation in rare disease care and help PANTHERx serve more patients while preserving its independent, patient-first model NEW YORK and PITTSBURGH, July 13, 2026 /PRNewswire/ -- Warburg Pincus, the pioneer of global growth investing, today announced that...